1 | Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma. 2023;28:1506 doi: 10.3390/molecules28031506 |
2 | |
3 | The Use of Photodynamic Therapy in the Treatment of Brain Tumors—A Review of the Literature. 2022;27:6847 doi: 10.3390/molecules27206847 |
4 | Near Infrared-Activatable Methylene Blue Polypeptide Codelivery of the NO Prodrug via π–π Stacking for Cascade Reactive Oxygen Species Amplification-Mediated Photodynamic Therapy. 2023;15:12750 doi: 10.1021/acsami.2c21280 |
5 | 9781510628335 DOSINDYGO: DOSe finding for INtraoperative photoDYnamic therapy of GliOblastoma; 2019; 17th International Photodynamic Association World Congress;194 doi: 10.1117/12.2524949 |
6 | |
7 | |
8 | Photodynamic Opening of the Blood–Brain Barrier Using Different Photosensitizers in Mice. 2019;10:33 doi: 10.3390/app10010033 |
9 | |
10 | Photodynamic therapy in glioblastoma: Detection of intraoperative inadvertent 5-ALA mediated photodynamic therapeutical effect after gross total resection. 2022;12: doi: 10.3389/fonc.2022.1080685 |
11 | Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies. 2023;15: doi: 10.1002/wnan.1838 |
12 | |
13 | Photodynamic Opening of the Blood–Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors. 2022;14:2612 doi: 10.3390/pharmaceutics14122612 |
14 | A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen. 2020;10:51 doi: 10.3390/brainsci10010051 |
15 | Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine. 2019;7: doi: 10.1186/s40425-019-0826-3 |
16 | |
17 | Unraveling of Functional Activity of Primary Hippocampal Neuron-Glial Networks in Photodynamic Therapy Based on Tetracyanotetra(aryl)porphyrazines. 2022;11:1212 doi: 10.3390/cells11071212 |
18 | Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer. 2023;15:285 doi: 10.1166/sam.2023.4438 |
19 | Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events. 2021;99:1024 doi: 10.1002/jnr.24776 |
20 | Transcranial Photosensitizer-Free Laser Treatment of Glioblastoma in Rat Brain. 2023;24:13696 doi: 10.3390/ijms241813696 |
21 | Supramolecular dye nanoassemblies for advanced diagnostics and therapies. 2024;9: doi: 10.1002/btm2.10652 |
22 | |
23 | Bibliometric and visualization analysis in the field of epigenetics and glioma (2009–2024). 2024;14: doi: 10.3389/fonc.2024.1431636 |
24 | Photochemically-Mediated Inflammation and Cross-Presentation of Mycobacterium bovis BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice. 2022;13: doi: 10.3389/fimmu.2022.815609 |
25 | Amphiphilic Chlorin‐β‐cyclodextrin Conjugates in Photo‐Triggered Drug Delivery: The Role of Aggregation. 2024;89: doi: 10.1002/cplu.202300743 |
26 | Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors. 2023;192:114643 doi: 10.1016/j.addr.2022.114643 |
27 | Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer. 2022;9: doi: 10.1002/advs.202202914 |
28 | DNA Strand Break Properties of Protoporphyrin IX by X-ray Irradiation against Melanoma. 2020;21:2302 doi: 10.3390/ijms21072302 |
29 | |
30 | Stereotactic photodynamic therapy for recurrent glioblastoma. Case report and literature review. 2020;84:81 doi: 10.17116/neiro20208405181 |
31 | Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy. 2020;12:11008 doi: 10.1039/C9NR10674J |
32 | Expression and Clinical Significance of Lymphocyte Subpopulations and Peripheral Inflammatory Markers in Glioma. 2024;Volume 17:9423 doi: 10.2147/JIR.S474577 |
33 | |
34 | |
35 | Efficacy of ruthenium coordination complex–based Rutherrin in a preclinical rat glioblastoma model. 2019;1: doi: 10.1093/noajnl/vdz006 |
36 | |
37 | Photodynamic-based combinatorial cancer therapy strategies: Tuning the properties of nanoplatform according to oncotherapy needs. 2022;461:214495 doi: 10.1016/j.ccr.2022.214495 |
38 | |
39 | |
40 | |